Biostate AI
Biostate AI is a Houston-based precision-health biotechnology company combining proprietary wet-lab chemistry with generative AI to make RNA and DNA sequencing dramatically cheaper and more accessible. Its BIRT (Barcode-Integrated Reverse Transcription) plus PERD (Probes for Excess RNA Depletion) platform delivers Total RNA sequencing from around $60 per sample, and its N-Act and RNAstate AI models turn omics data into clinical insights for autoimmune, cardiovascular, and cancer diagnostics. The company operates a cloud data lake for AI-ready omics data and runs research partnerships across the U.S., India, and China. As of this profile Biostate publishes a marketing and publications site plus open research model repositories on GitHub, but exposes no public developer API, OpenAPI, SDK client library, or developer portal.
Biostate AI is profiled on the APIs.io network. Tagged areas include Company, Ai, RNA Sequencing, Genomics, and Bioinformatics.
Biostate AI’s developer surface includes engineering blog, pricing, and 6 more developer resources.
Kin Score
Security Posture 1
Authentication, domain security, vulnerability disclosure, and trust-center signals.
Resources
Build 1
SDKs, sample code, and the tooling you integrate with
Access & Security 1
Authentication, authorization, and security posture
Commercial 3
Pricing, plans, and the legal terms of use
Company 2
The organization behind the API
Other 1
Properties that don't map to a standard resource type